Electronic Pharmacotherapy Risk Management

Pain Clinical Trial

— ePRM  

Official title:

Developing a Utah Pharmacotherapy Risk Management System With an Electronic Surveillance Tool (Utah ePRM)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00828490
• Other study ID #: 24987
• Secondary ID: 7570516-1
• Status: Completed
• Phase: N/A
• First received: January 23, 2009
• Last updated: March 21, 2010
• Start date: July 2007
• Est. completion date: March 2010

Study information

• Verified date: March 2010
• Source: University of Utah
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of the Utah ePRM (electronic Pharmacotherapy Risk Management) project is to improve quality and safety of medication use while simultaneously controlling costs and detecting fraud and abuse.

Description:

The ePRM project has two objectives:

1. Refine and implement a computerized surveillance and trigger tool to support medication therapy and risk management services. The ePRM tool will be used to (1) identify potential drug-therapy problems, which include quality, safety and cost-related problems; (2) select patients and providers for in-depth clinical reviews and possibly direct intervention (i.e., letter, phone call, Medication Therapy Management Services (MTMS), or Academic Detailing); (3) identify potential fraud and diversion of controlled substances; and (4) track patterns of medication use and evaluate ePRM performance, identify improvements, and direct policy change.

2. Conduct innovative multi-pronged interventions that are guided by the ePRM trigger tool. Clinical areas chosen for review include diabetes therapy, hypertension, asthma, antipsychotic therapy, pain management (opioid narcotics and anticonvulsants) and anticoagulation/antiplatelet drugs. Interventions in these areas will address potential under and overuse, or patient safety concerns. Clinical pharmacists and physicians will implement five types of inter-related interventions: a) provider level reviews, which includes prescribers' profiling and feedback for outlier prescribers; b) patient level reviews and letters to prescribers for high-risk patients; c) phone consultation and Academic Detailing with outlier prescribers; d) MTMS; and e) detecting and pursuing suspected fraud and abuse cases.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 174000
• Est. completion date: March 2010
• Est. primary completion date: March 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• All medicaid recipients and providers with in the salt lake area

Exclusion Criteria:

• each participant much be a Medicaid recipient

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Asthma
• Mental Health
• Pain

Intervention

Behavioral:
• provider feedback
The provider-level intervention includes a targeted review of trigger-flagged beneficiaries' drug utilization history and an information packet sent to providers which includes patient-specific pharmacy and medical claims history, patient specific recommendations, and provider comparative profiling.
• patient intervention
The patient intervention arm includes the provider-level intervention mentioned above in addition to Medication Therapy Management Services (MTMS), a program that provides patients one-on-one therapy counseling administered by community pharmacists who have completed an MTMS certificate program.
• Process-level
The process-level intervention includes the provider-level intervention plus in-clinic evidence-based quality improvement workshops with opportunity for CME credit

Locations

Country	Name	City	State
United States	Multi-clinic site	Salt Lake City	Utah

Sponsors (2)

Lead Sponsor	Collaborator
University of Utah	Utah Department of Health

Country where clinical trial is conducted

United States,